News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeoStem, Inc.'s Subsidiary, PCT, Adds Key Personnel: Robert Shaw, Vice President of Commercial Sales, and Brian Hampson, Senior Director, Engineering and Innovation


8/12/2013 9:40:36 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALLENDALE, N.J., Aug. 12, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("the Company"), a leader in the emerging cellular therapy industry, and its subsidiary, Progenitor Cell Therapy, LLC ("PCT"), an internationally recognized contract development and manufacturing organization, announced today the addition of two new leaders to the PCT team-Robert ("Bob") Shaw as Vice President of Commercial Sales, and Brian Hampson, as Senior Director, Engineering and Innovation.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES